晚期皮肤状细胞癌中的表皮生长因子受体抑制剂:系统性审查和元分析
James P Pham1,2, Anthony Rodrigues1,2, Simone M Goldinger3
1Department of Medical Oncology, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia.
Experimental dermatology
|November 16, 2023
概括
表皮生长因子受体 (EGFR) 抑制剂在晚期皮肤状细胞癌 (cSCC) 患者中显示出26%的客观反应率,这些患者对抗PD1疗法有抗性. 虽然它们与显著的不良事件有关,但它们提供了一个可行的治疗选择.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 晚期皮肤状细胞癌 (cSCC) 对那些对抗PD1免疫疗法没有反应的患者提供了有限的治疗选择.
- 外皮生长因子受体 (EGFR) 抑制剂正在被探索,但来自小型试验的证据需要进一步调查.
结论:
- EGFR抑制剂代表了晚期cSCC患者的潜在治疗策略,这些患者正在进行或禁用抗PD1免疫疗法.
- 需要进一步的研究来评估抗PD1治疗后的活性和安全性,确定预测生物标志物,并探索组合疗法.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K


